Multimedia download archive
Our featured thinking
Explore our thinking
Healthcare, higher education and not-for-profit, Spring 2011
Healthcare, higher education and not-for-profit, Spring 2011
Webcast
Originally hosted on May 17th 2011, this one-hour webcast focuses on hot topics and technical updates impacting tax reporting for healthcare and higher education and not-for-profit organizations.
Prospering in a post-health reform world Fall 2010
Prospering in a post-health reform world Fall 2010
Webcast
Originally hosted on September 10, 2010 with DLA Piper — a well respected national law firm. The 90-minute webcast addresses how health reform will impact US employers.
Tax year in review: Health reform, tax-exempt bond financing and other issues impacting healthcare provider, universities and other tax-exempt organizations, December 2010
Tax year in review: Health reform, tax-exempt bond financing and other issues impacting healthcare provider, universities and other tax-exempt organizations, December 2010
Webcast
This program originally hosted on December 8, 2010 addresses the following topics:
- The Patient Protection and Affordable Care Act, and the impact of health reform on organizations like yours
- Tax-exempt bond update
- IRS update including increased audit activity, employment tax, unrelated business income tax, and governance matters
- Form 990 changes
- State and local tax developments
Prospering in a post-health reform world Spring 2010
Prospering in a post-health reform world Spring 2010
Webcast
On Friday, April 23rd PwC hosted a webcast, ‘Health reform: Prospering in a post-reform world.’ The one hour program hosted by PwC's Health Research Institute explains meaningful details of the reform legislation and the potential ramifications for businesses and the health industries.
US healthcare reform: October 15, 2009
US healthcare reform: A briefing on the major business and tax impacts affecting pharmaceutical, medical device and biotechnology companies
Webcast
Originally held on October 15, 2009, speakers included Michael F. Swanick, Global Pharmaceutical and Life Sciences Tax Leader, Todd Evans, Director, US Pharmaceutical and Life Sciences Advisory Services, and Jack Rodgers, Managing Director, Health Policy Economics.
IFRS conversion: Winter 2009
IFRS conversion: Winter 2009
Webcast
Key discussion topics include planning considerations and tax accounting method changes.
Audioconference: Sales & Marketing Disclosure Requirements Update: Winter 2009
Audioconference: Sales & Marketing Disclosure Requirements Update on Sales and Marketing Disclosure Requirements for Drug, Device and Biotech Companies: Winter 2009
Webcast
Update on Sales and Marketing Disclosure Requirements for Drug, Device and Biotech Companies
New Cost Sharing Regulations and Implications for the Pharma, Life Sciences and Medical Device Companies: Spring 2009
New Cost Sharing Regulations and Implications for the Pharma, Life Sciences and Medical Device Companies: Spring 2009
Webcast
Host: Michael F. Swanick, Global Pharmaceutical and Life Sciences Tax Leader
Guest: Horacio Pena, Pharmaceutical and Life Sciences Transfer Pricing Leader
Key discussion topics will include:
- Basic Requirements for Cost Sharing Arrangements
- Platform Contributions (PCTs)
- Application of periodic trigger adjustment to the PCT
- Transition Rules
US Tax Reform Proposals and the New Irish Intellectual Property Rules: Summer 2009
US Tax Reform Proposals and the New Irish Intellectual Property Rules — Impact on Pharma, Life Sciences and Medical Device Companies: Summer 2009
Webcast
Discussion topics included:
Obama’s International tax proposals including the disallowance of foreign related expenses, modifications to the Check the box and foreign tax credit rules.
Irish IP Regime:
- Overview of existing system - 12.5% tax rate
- New IP regime effective May 2009
- Tax Allowances provided
- Definition of IP
- Application to group and third party IP
- Substance of IP company
Straight Talk: Looking at health system disaster preparedness
Straight Talk: Looking at health system disaster preparedness
Podcast
When — not if — a large-scale disaster hits, Americans expect a carefully orchestrated and sequenced response from hospitals, emergency workers and public health officials. In their greatest time of need, the system may fail them unless disaster preparedness becomes a greater priority. In this podcast, we discuss the steps health executives should take to ensure an effective response to a disaster.
President-Elect Obama’s Plans for Healthcare and Tax: Winter 2008
President-Elect Obama’s Plans for Healthcare and Tax: Winter 2008
Webcast
A briefing on the major business and tax impacts affecting pharmaceutical, medical device and biotechnology companies. Key Drivers for Health and Tax Legislation in 2009-2010. Possible Health and Tax Legislation in early 2009. Impact of Health Reform and Tax Reform Proposals on the Pharmaceutical, Life Sciences and Medical Devices Industry.
Key Drivers for Health and Tax Legislation in 2009-2010. Possible Health and Tax Legislation in early 2009. Impact of Health Reform and Tax Reform Proposals on the Pharmaceutical, Life Sciences and Medical Devices Industry.
Proposals to policy: A national conversation on healthcare reform. Recorded broadcast from the National Press Club, Washington, D.C. November 20, 2008
Proposals to policy: A national conversation on healthcare reform. Recorded broadcast from the National Press Club, Washington, D.C. November 20, 2008
Webcast
Originally held on November 20th in Washington DC, Susan Dentzer, editor-in-chief of Health Affairs and health correspondent of The NewsHour, moderated a panel of healthcare experts, economists and lawmakers as they discussed President Obama’s healthcare reform proposals.
Health reform on the fast track: Spring 2009
Health reform on the fast track: Spring 2009
Webcast
Originally held March 11, 2009, this webcast discusses the impact President Obama’s stimulus package and the $630 billion reserve will have. The webcast also addresses the potential implications of these reforms (positive and negative) for pharmaceutical firms, health insurers (payers), hospitals (providers) and employers
- Kelly Barnes
- US health industries leader
- Tel: +1 (214) 754 5172
- Robert Dondero
- US health industries advisory leader
- Tel: +1 (214) 754 7448
